Avacta Group plc (GB:AVCT) has released an update.
Avacta Group plc, a life sciences company specializing in targeted oncology drugs and diagnostics, has announced the availability of its Annual Report for 2023 and the upcoming AGM on June 26, 2024. Shareholders are encouraged to pre-register their interest to attend the AGM due to limited capacity, with all materials to be accessible online post-event. The company continues to advance its proprietary platforms, including the AVA6000 program, which shows promising clinical activity and improved patient safety.
For further insights into GB:AVCT stock, check out TipRanks’ Stock Analysis page.
